Thursday, 10 July 2014
Researchers from the Folding and
Conformational Diseases Group at the Institute of Biotechnology and Biomedicine Group
are part of the European project Neuromed to develop molecules and detect
biomarkers of this disease before the signs of neurodegeneration become
Monday, 02 December 2013
composed of researchers María Isabel Pividori, Ona Illa and Jean-Didier
Maréchal from the Chemistry Dept. and Jofre Ferrer from IBB have been awarded
the second place in the Ideas Generation program from the PRUAB.
1500€, the Celifast project proposes the development of a Point-of-Care biosensor for the rapid
diagnosis of Celiac Disease using a drop of blood. The baseline technology has
already been tested using clinical samples and has shown a sensitivity of 100%.
Its great advantage is giving real time results, thus becoming a faster and less
invasive alternative to the currently available tests for gluten intolerance.
It is hoped that the diagnostic’s Point-of-Care approach will have a positive impact
– specially for the youngest patients – in reducing the future risk of
complications due to a late diagnosis.